Adgero Biopharmaceuticals Holdings, Inc. Business Finance Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Warrant Agent Agreement, dated August 14, 2017, between the Company and Aegis Capital Corp
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Second Amendment to Registration Rights Agreement
Registration Rights Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Subscription Agreement for the Company's December 2016 Private Placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and Steven Rychnovsky, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
8% Convertible Note, dated November 26, 2012, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Amendment to 6% Convertible Note, dated March 21, 2016, among Adgero Biopharmaceuticals, Inc. and Adam Stern
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
6% Convertible Note, dated December 23, 2015, among Adgero Biopharmaceuticals, Inc. and Adam Stern
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Amendment to 6% Convertible Note, dated March 28, 2016, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
6% Convertible Note, dated October 28, 2015, among Adgero Biopharmaceuticals, Inc. and Roman Perez-Soler, MD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Amendment to 6% Convertible Note, dated March 25, 2016, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
6% Convertible Note, dated October 6, 2015, among Adgero Biopharmaceuticals, Inc. and Robert F. Hendrickson
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Amendment to Asset Purchase Agreement, dated May 12, 2014, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Purchase Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Asset Purchase Agreement, dated as of November 26, 2012, among Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC
Purchase Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Amendment to Promissory Note, dated December 30, 2015, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Promissory Note, dated July 9, 2014, among Adgero Biopharmaceuticals, Inc. and Frank Pilkiewicz, PhD
Note Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NJ
2017
Form of Subscription Agreement for the Companys August private placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Restricted Stock Agreement
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Form of Non-Qualified Stock Option Agreement
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
DE
2017
Form of Subscription Agreement for the Companys 2016 private placement
Subscription Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of December 2016 Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Common Stock Certificate
Stock Agreements
Adgero Biopharmaceuticals Holdings, Inc.
2017
Form of August Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Registration Rights Agreement
Registration Rights Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Placement Agent Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Investor Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017
Form of Replacement Warrant
Warrant Agreements
Adgero Biopharmaceuticals Holdings, Inc.
NY
2017